Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2128004 | European Journal of Cancer Supplements | 2012 | 5 Pages |
Abstract
This article describes the achievements of the Cutaneous LymphomaTask Force (CLTF) over the recent decade in their goal to optimize classification and response criteria and establish new treatment options for patients suffering from cutaneous T-cell lymphomas (CTCL). Collaborative work with the International Society of Cutaneous Lymphoma (ISCL) and the United States Cutaneous Lymphoma Consortium (USCLC) has led to publication of pivotal manuscripts proposing revised staging proposals for Mycosis fungoides (MF)/Sézary syndrome (SS) and also non MF/SS primary cutaneous lymphomas as well as the recent publication of a proposal for defining endpoints in MF/SS.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Sean Whittaker, Robert Knobler, Pablo Ortiz, Maarten Vermeer, Matthias Karrasch, Baktiar Hasan, Denis Lacombe, Werner Kempf, Reinhard Dummer, Martine Bagot,